The effectiveness and value of oveporexton for narcolepsy. [PDF]
Nikitin D +6 more
europepmc +1 more source
New developments in the management of narcolepsy
Vivien C Abad, Christian Guilleminault Department of Psychiatry and Behavioral Sciences, Division of Sleep Medicine, Stanford University Outpatient Center, Redwood City, CA, USA Abstract: Narcolepsy is a life-long, underrecognized sleep disorder ...
Guilleminault C, Abad VC
core
Symptom improvement with dosing above 9 g of low-sodium oxybate: effectiveness and safety in participants with narcolepsy in the DUET study. [PDF]
Simmons JH +10 more
europepmc +1 more source
Psychometric properties of the novel patient-reported Functional Impacts of Narcolepsy Instrument (FINI) using data from phase 3 clinical trials in narcolepsy type 1. [PDF]
Romero H +5 more
europepmc +1 more source
Case Report: Narcolepsy associated with anti-Ma2 antibody positivity. [PDF]
Lv Y, Lv H, Huang Y, Long X, Zhou J.
europepmc +1 more source
Medico-Legal Aspects of Disability in Narcolepsy
Narcolepsy is a severe, chronic, disabling disease affecting almost all personal and social activities. The detrimental effect of narcolepsy on patients’ working lives may be severe and long-lasting, but the impairment due to narcolepsy varies widely ...
PLAZZI, GIUSEPPE, INGRAVALLO, FRANCESCA
core
The role of histamine in narcolepsy type 1: a narrative review. [PDF]
Liang W +6 more
europepmc +1 more source
Mignot and Yanagisawa win Lasker prize for discovery of the role of orexins in wake, sleep, and narcolepsy. [PDF]
Saper CB.
europepmc +1 more source
Assessing mortality risk in narcolepsy: Evidence from population studies. [PDF]
Alhassan N, Karki S, Lal J.
europepmc +1 more source

